Form 4: Precigen CFO Harry Thomasian Jr. Exercises RSUs

Precigen CFO Harry Thomasian Jr. acquired 87,500 shares of common stock through the vesting of restricted stock units.

Summary

• CFO Harry Thomasian Jr. exercised 87,500 restricted stock units (RSUs) on May 23, 2026.
• The transaction resulted in the acquisition of 87,500 shares of Precigen common stock.
• Following the transaction, the reporting person holds a total of 596,419 shares of common stock.
• The RSUs vested as part of a grant originally issued on June 26, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the standard fulfillment of executive compensation agreements.

Positives

• The transaction reflects the vesting of equity-based compensation, aligning the CFO's interests with long-term shareholder value.

Negatives

• None identified; this is a standard equity compensation vesting event.

Risks

• The remaining unvested RSUs are subject to continued employment and future vesting schedules.

Future Outlook

The remaining RSUs from the June 26, 2025 grant are scheduled to vest in equal quarterly installments over the next three years.

Industry Context

StockSavvy.ai notes that executive equity vesting is a routine corporate governance activity and does not typically signal a change in company strategy or market outlook.

Comparison to Industry Standards

• The vesting schedule and equity compensation structure are consistent with standard practices for biotechnology and life sciences companies.

Stakeholder Impact

• Increased share ownership by the CFO may be viewed positively by shareholders as it increases the executive's 'skin in the game'.

Next Steps

• Continued quarterly vesting of the remaining RSUs over the next three years.

Key Dates

Keywords

Precigen, PGEN, Form 4, Insider Trading, Equity Compensation, CFO